Investment Decision for Scancell Ltd. in Biopharmaceutical Industry

Investment Decision

Table of Contents
INTRODUCTION...........................................................................................................................3
MAIN BODY...................................................................................................................................3
1. Background and introduction about the industry...............................................................3
2. Introduction and background of the company Scancell Ltd...............................................4
3. Qualitative analysis on basis of various reports published by the company......................5
4. Compute the financial ratios of the company for the year 2020 and 2021.........................5
5. Do a comparative analysis of the financial performance of the company.........................6
6. Comparative analysis of company with industry...............................................................7
CONCLUSION................................................................................................................................7
REFERENCES................................................................................................................................8

INTRODUCTION
The investment decision means that how the money of the company is being invested into
various assets, which can make the business earn more amount of returns for the investors. These
decisions are taken for the long term to maintain the sustainability of the business. To manage
the financial resources adequately, and to maintain a steady growth the company needs to do a
market analysis of the financial state of competitors so that it can be improved by looking at the
fiscal state of the industry (Altman and et. al., 2017). In this report, the company chosen is
Scancell Ltd., which is in a biopharmaceutical industry. It is based in UK and headquartered in
England and Wales. The report discusses about the background of the organisation and chosen
company's industry along with its background. Further the qualitative analysis of the potential
stakeholders, director's, investors, client and many more is done. Moreover, the financial ratios
of the company are calculated.
MAIN BODY
1. Background and introduction about the industry.
A subcategory of pharmaceutical is biopharmaceutical. Drugs are the other major subset of
pharmaceuticals, with their source and manufacture being non – biological chemical. These are
pharmaceuticals that are inherently biological in nature and manufactured using biotechnology
involving the use of live organisms, whereas drugs are pharmaceuticals that are chemical are
non-biological in nature (da Fonseca, 2020). These molecules are made using biotechnology
procedures, and the results clearly have biological sources, usually including live organisms or
their active components or directly involving surrogates, such as protein or gene sequences.
Biopharmaceuticals in the United States and Europe have accepted this comprehensive
definition, which encompasses all recombinant proteins, antibodies, vaccinations, blood or
plasma-derived products and cultured cells and tissues. The biopharmaceutical sector is divided
into three primary segments: diagnostics, vaccines, and recombinant therapeutic proteins. U.S is
the biggest base of the biopharmaceuticals industry. It has grown a lot over the last two decades
because of the several disease spreading all over the world. It helps in making the procurement
medicines by testing the various chemical and the human organisms which can be helpful in
detecting the viruses.